Find Articles in:
All
Business
Reference
Technology
News
Lifestyle

Schering-Plough, marketer of high-profile allergy products Claritin and Clarinex, last month decided not to exercise its option agreement related to ALK-Abello's grass-pollen allergy tablet and other non-injectable allergy products

Drug Store News, Jan 19, 2004

Schering-Plough, marketer of high-profile allergy products Claritin and Clarinex, last month decided not to exercise its option agreement related to ALK-Abello's grass-pollen allergy tablet and other non-injectable allergy products, the company reported.

ALK-Abello has reacquired the exclusive worldwide. rights to these products, ending the collaboration the two companies entered in October 2002.

Given that many prescription allergy medications are either switching to OTC or are in danger of being forced OTC, introducing a prescription-only allergy remedy may not be as promising as it once was.

COPYRIGHT 2004 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

The following tags are supported in BNET comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. You are currently a guest | Login?
advertisement
Go
advertisement
  • Click Here
  • Click Here
advertisement

Content provided in partnership with http://findarticles.com/source//